Managing the adverse effects of interferon-beta therapy in multiple sclerosis.

Managing the adverse effects of interferon-beta therapy in multiple sclerosis.

Item
http://www.wikidata.org/entity/Q33836477
Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosisOptimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence.Patient satisfaction following transition from the original to the new formulation of subcutaneous interferon beta-1a in relapsing multiple sclerosis: a randomized, two-arm, open-label, Phase IIIb studyKnowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon betaMultiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature reviewEffect of drugs in secondary disease progression in patients with multiple sclerosis.Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management.Interferon-beta treatment for multiple sclerosis.Adherence to first-line disease-modifying therapy for multiple sclerosis in kuwaitAddressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?Nurses' perspective on approaches to limit flu-like symptoms during interferon therapy for multiple sclerosis.Interferon beta-1b-induced postmenopausal bleeding in a patient with multiple sclerosis.Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-1a (AVONEX) therapy.Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis.Patient satisfaction and healthcare services in specialized multiple sclerosis centres in Germany.Disease-modifying agents in the Sonya Slifka Longitudinal Multiple Sclerosis Study.Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.
P2860

Managing the adverse effects of interferon-beta therapy in multiple sclerosis.

Item
http://www.wikidata.org/entity/Q33836477
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Managing the adverse effects of interferon-beta therapy in multiple sclerosis.
@ast
Managing the adverse effects of interferon-beta therapy in multiple sclerosis.
@en
type
label
Managing the adverse effects of interferon-beta therapy in multiple sclerosis.
@ast
Managing the adverse effects of interferon-beta therapy in multiple sclerosis.
@en
prefLabel
Managing the adverse effects of interferon-beta therapy in multiple sclerosis.
@ast
Managing the adverse effects of interferon-beta therapy in multiple sclerosis.
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Managing the adverse effects of interferon-beta therapy in multiple sclerosis.
@en
P2093
P2888
P304
P31
P356
10.2165/00002018-200022020-00006
P433
P478
P577
P6179
P698
P921